Knight Therapeutics | GUD - Current Assets



Knight Therapeutics reported CAD397.57M in Current Assets for its fiscal quarter ending in September of 2024.


Current Assets Change Date
Acasti Pharma USD 20.52M 8.58M Jun/2025
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Aurora Cannabis CAD 465.3M 28.91M Jun/2025
Avita Medical AUD 57M 15.96M Dec/2024
Canopy Growth CAD 303.36M 37.72M Jun/2025
Cronos Group USD 927.15M 8.57M Jun/2025
Dianthus Therapeutics USD 263.6M 17.3M Jun/2025
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
IQVIA Holdings USD 6.35B 434M Jun/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Moderna USD 6.17B 595M Jun/2025
Organigram Holdings CAD 277.78M 46.29M Jun/2025
Organon & Co USD 4.62B 247M Jun/2025
Revvity USD 2.24B 81.76M Jun/2025
Tectonic Therapeutic USD 290.85M 143.99M Jun/2025
Tilray USD 707.34M 18.54M Nov/2024
Viatris USD 9.77B 152.2M Jun/2025
Xeris Pharmaceuticals USD 185.58M 17.92M Jun/2025